A detailed history of Fairfield Financial Advisors, LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Fairfield Financial Advisors, LTD holds 5,216 shares of BSX stock, worth $535,631. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,216
Previous 2,641 97.5%
Holding current value
$535,631
Previous $284 Million 79.52%
% of portfolio
0.17%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$97.03 - $108.14 $249,852 - $278,460
2,575 Added 97.5%
5,216 $509 Million
Q2 2025

Aug 01, 2025

BUY
$89.7 - $107.41 $4,036 - $4,833
45 Added 1.73%
2,641 $284 Million
Q1 2025

May 09, 2025

BUY
$89.38 - $106.18 $178,402 - $211,935
1,996 Added 332.67%
2,596 $262 Million
Q4 2024

Feb 07, 2025

BUY
$83.62 - $91.5 $50,172 - $54,900
600 New
600 $53.6 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Fairfield Financial Advisors, LTD Portfolio

Follow Fairfield Financial Advisors, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield Financial Advisors, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fairfield Financial Advisors, LTD with notifications on news.